New screening and diagnostic tests for prostate cancer and immunologic assessment.
D000951:Antigens, Neoplasm / Q000032:analysis; D002272:Carcinoembryonic Antigen / Q000032:analysis; D002784:Cholesterol / Q000652:urine; D006063:Chorionic Gonadotropin / Q000032:analysis; D003402:Creatine Kinase / Q000097:blood; D005353:Fibronectins / Q000652:urine; D006801:Humans; D006909:Hydroxyproline / Q000652:urine; D007111:Immunity, Cellular; D007527:Isoenzymes; D007532:Isoleucine / Q000652:urine; D007770:L-Lactate Dehydrogenase / Q000097:blood; D007957:Leukocyte Adherence Inhibition Test; D008297:Male; D008403:Mass Screening / Q000379:methods*; D009961:Orosomucoid / Q000032:analysis; D011471:Prostatic Neoplasms / Q000097:blood / Q000201:enzymology / Q000517:prevention & control* / Q000652:urine; D012260:Ribonucleases / Q000097:blood; D013095:Spermidine / Q000652:urine; D000509:alpha-Fetoproteins / Q000032:analysis
D000951:Antigens, Neoplasm; D002272:Carcinoembryonic Antigen; D006063:Chorionic Gonadotropin; D005353:Fibronectins; D007527:Isoenzymes; D009961:Orosomucoid; D000509:alpha-Fetoproteins; D007532:Isoleucine; D002784:Cholesterol; D007770:L-Lactate Dehydrogenase; D003402:Creatine Kinase; D012260:Ribonucleases; D006909:Hydroxyproline; D013095:Spermidine